PALI
Palisade Bio Inc
1.40$
+0.7%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | -100.0% | – | – | – | – | – | – | |
| – | +5,300.0% | -98.1% | +0.0% | +0.0% | +100.0% | -50.0% | +0.0% | – | – | – | – | – | |
| – | – | – | – | – | – | -150.0% | – | – | – | – | – | – | |
| – | -34.8% | +61.5% | +18.7% | -18.7% | -2.5% | -54.4% | +76.3% | -16.8% | +342.8% | +3.6% | +15.7% | – | |
| – | -6.9% | -6.4% | +8.5% | -8.0% | -10.9% | +4.8% | -14.1% | +30.8% | +149.2% | +14.3% | +10.3% | – | |
| – | -16.5% | +16.4% | +14.7% | -14.7% | -5.9% | -31.7% | +23.1% | +2.8% | +241.6% | +7.7% | +13.5% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -50.0% | -75.0% | +100.0% | +200.0% | -50.0% | -66.7% | +100.0% | +150.0% | -60.0% | -50.0% | -100.0% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.